Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;19(3):675-80.
doi: 10.1158/1055-9965.EPI-09-1051. Epub 2010 Feb 16.

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer

Affiliations

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer

Ying Liu et al. Cancer Epidemiol Biomarkers Prev. 2010 Mar.

Erratum in

  • Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1661

Abstract

Background: Accurate breast cancer recurrence risk perceptions might motivate health-promoting behaviors and alleviate undue anxiety. Although a few studies have examined early-stage breast cancer survivors' perceived risk of recurrence, none have assessed the accuracy of survivors' perceived risk of recurrence.

Methods: First primary ductal carcinoma in situ and early-invasive breast cancer survivors reported their perceived risk of recurrence during 6- and 12-month postsurgery interviews. We estimated the patients' 10-year risk of recurrence from published clinical trials, and for early-invasive breast cancer patients, risk of distant recurrence was based on their breast cancer-specific mortality calculated using Adjuvant! Online. Patients' perceived risk was compared with their calculated risk and categorized as "Accurate," "Underestimated," "Overestimated," and "Uncertain." Multinomial logit marginal effect models were fitted using Accurate as the reference.

Results: Only 17% of 531 patients accurately perceived their risk at 6 months, most of whom inaccurately perceived their risk at 12 months (P = 0.0143). Patients who were nonwhite [odds ratio (OR), 1.70; 95% confidence interval (95% CI), 1.12-2.56] and received radiation therapy (OR, 2.01; 95% CI, 1.07-3.77) were more likely to underestimate their risk. Patients with ductal carcinoma in situ (OR, 1.76; 95% CI, 1.11-2.79), [corrected] lower social support (OR, 0.71; 95% CI, 0.53-0.95), and anxiety (OR, 1.58; 95% CI, 1.01-2.47) were more likely to overestimate their risk.

Conclusion: Few breast cancer survivors accurately perceived their risk of recurrence.

Impact: The accuracy of perceived risk may be increased by better physician-patient communications about their prognosis, provision of social support, and treatment for coexisting anxiety.

PubMed Disclaimer

Figures

Figure
Figure
Distributions of early-stage breast cancer patients' perceived risk of recurrence and individualized calculated risk of recurrence at six months after definitive surgical treatment.

References

    1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106. - PubMed
    1. Rothrock NE, Matthews AK, Sellergren SA, Fleming G, List M. State anxiety and cancer-specific anxiety in survivors of breast cancer. J Psychosoc Oncol. 2004;22:93–109.
    1. Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100:243–51. - PubMed
    1. Rosenstock IM, Irwin M. The Health Belief Model: explaining health behavior through expectancies. In: Glanz K, Lewis FM, Rimer BK, editors. Health Behavior and Health Education: Theory, Research, and Practice. San Francisco, CA, US: Jossey-Bass; 1990. pp. 39–62.
    1. Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77:285–93. - PubMed

Publication types